In the first study of its kind, stem cell researchers is on a clinical trial to find out the determine if injecting a patient’s own stem cells will help patients in heart failure.The yearlong, five-center study will look at safety and whether injecting “cardiac repair cells” improves heart function. It’s the first study in the country on treating both ischemic and non-ischemic heart failure, including the 40 percent for which no cause is known.
For the first time, stem cell presents a hope for the Pulmonary Hypertension. Dr. Leonel Fernandez Liriano, Professor of Medicine at Pontifical Catholic University School of Medicine (PCUSM), announced nine month follow up results for the first patient treated with engineered stem cells in a clinical study of primary pulmonary hypertension. Moreover, the stem cells were taken from the patient’s own blood.
As a step to keep pace with the world in stem cell research, Russia announced to invest 120 million Russian rubles. The research will focus on three aspects of stem cell research: developing stem cell technologies and treatment for traumatic skin injures; diabetes stem cell therapy and the utilization of stem cells in treating cardio-vascular diseases, including heart attacks.
Dubai doctor is successful in treating the end-stage cardiac diseases using Autologous Adult Stem Cell Therapy. The doctor, Zannos Grekos, MD presented clinical data this week to the Dubai Congress on Regenerative Biomedical Technologies.
Los Angeles based leading biotechnology company Capricor Inc. today announced results of the preclinical studies of its cardiosphere-derived stem cells. The study shows possibility to protect the heart significantly better, when the cell is transplanted into a well-established mouse model of myocardial infarction (MI).
According to cardiologists hundreds and thousands of babies born every year with defective hearts, heart valve abnormalities are one of the most common kinds of inherited heart defects In these babies.
It can be called a major step towards the use of stem cell therapies for heart disease. The researchers in the University of Bristol, found that our bodies’ ability to respond to an internal ‘mayday’ signal may hold the key to success for long-awaited regenerative medicine. Their findings also provide a practical step to advance progress in stem cell therapies.
A Britain stem cell clinical trial has raised hope for those heart patients. The study finds that a heart patient could dramatically improve survival and quality of life, if the stem cell from his own heart can be delivered into his heart.